Patrick Bühler
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Radiopharmaceutical Chemistry and Applications
-
- Immunotherapy and Immune Responses
- Toxin Mechanisms and Immunotoxins
Papers in
-
- Prostate Cancer Treatment and Research 6
-
- Radiopharmaceutical Chemistry and Applications 4
- Monoclonal and Polyclonal Antibodies Research 3
- Co-authors
- Philipp Wolf (20 shared papers)Ursula Elsässer‐Beile (19 shared papers)Ulrich Wetterauer (12 shared papers)Dorothee Gierschner (10 shared papers)Karen Alt (7 shared papers)Wolfgang Schultze‐Seemann (4 shared papers)Stefan Wiehr (3 shared papers)Bernd J. Pichler (3 shared papers)
- Journals
- The Prostate (6 papers)Journal of Immunotherapy (2 papers)Cancer Immunology Immunotherapy (2 papers)Current Drug Targets (1 paper)Journal of Nuclear Medicine (1 paper)
- Partner nations
- GermanyUnited StatesHungary
In The Last Decade
Patrick Bühler
21 papers receiving 700 citations
Peers
Comparison fields: 5 of 58
- Radiology, Nuclear Medicine and Imaging 282
- Immunology 187
- Pulmonary and Respiratory Medicine 223
- Oncology 189
- Biomaterials 51
Countries citing papers authored by Patrick Bühler
This map shows the geographic impact of Patrick Bühler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Bühler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Bühler more than expected).
Fields of papers citing papers by Patrick Bühler
This network shows the impact of papers produced by Patrick Bühler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Bühler. The network helps show where Patrick Bühler may publish in the future.
Co-authors
The 25 scholars most cited alongside Patrick Bühler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 82 | |
| 2 | 2009 | 73 | |
| 3 | 2007 | 69 | |
| 4 | 2009 | 67 | |
| 5 | 2009 | 64 | |
| 6 | 2006 | 61 | |
| 7 | 2010 | 41 | |
| 8 | 2006 | 38 | |
| 9 | 2009 | 31 | |
| 10 | 2010 | 31 | |
| 11 | 2010 | 28 | |
| 12 | 2012 | 19 | |
| 13 | Influence of structural variations on biological activity of anti-PSMA scFv and immunotoxins targeting prostate cancer. | 2010 | 18 |
| 14 | 2007 | 16 | |
| 15 | In vivo testing of 177Lu-labelled anti-PSMA antibody as a new radioimmunotherapeutic agent against prostate cancer. | 2011 | 16 |
| 16 | 2009 | 14 | |
| 17 | 2014 | 14 | |
| 18 | Adjuvant intravesical treatment with a standardized mistletoe extract to prevent recurrence of superficial urinary bladder cancer. | 2006 | 12 |
| 19 | 2012 | 9 | |
| 20 | 2010 | 6 |
About Patrick Bühler
Patrick Bühler is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Immunology, Molecular Biology and Oncology, having authored 21 papers that have together received 712 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (6 papers), Toxin Mechanisms and Immunotoxins (5 papers), Radiopharmaceutical Chemistry and Applications (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Immunotherapy and Immune Responses (2 papers), Peptidase Inhibition and Analysis (2 papers), Protein purification and stability (1 paper) and Ubiquitin and proteasome pathways (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (282 citations), Immunology (187 citations), Pulmonary and Respiratory Medicine (223 citations), Oncology (189 citations) and Biomaterials (51 citations). Patrick Bühler has collaborated with scholars based in Germany, United States and Hungary. Frequent co-authors include Philipp Wolf, Ursula Elsässer‐Beile, Ulrich Wetterauer, Dorothee Gierschner, Karen Alt, Wolfgang Schultze‐Seemann, Stefan Wiehr, Bernd J. Pichler, Wolfgang W. Schamel and Nikolaus Freudenberg. Their work appears in journals such as The Prostate, Journal of Immunotherapy, Cancer Immunology Immunotherapy, Current Drug Targets and Journal of Nuclear Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.